Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic

SARS-CoV-2 antibody therapeutics are being evaluated in clinical and preclinical stages. As of 11 October 2020, 13 human monoclonal antibodies targeting the SARS-CoV-2 spike protein have entered clinical trials with three (REGN-COV2, LY3819253/LY-CoV555, and VIR-7831/VIR-7832) in phase 3. On 9 Novem...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yaping, Ho, Mitchell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717131/
https://www.ncbi.nlm.nih.gov/pubmed/33912795
http://dx.doi.org/10.1093/abt/tbaa025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717131/
https://www.ncbi.nlm.nih.gov/pubmed/33912795
http://dx.doi.org/10.1093/abt/tbaa025

Ejemplares similares